ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 172 filers reported holding ACCELERON PHARMA INC in Q3 2019. The put-call ratio across all filers is 1.95 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $36,000 | -18.2% | 924 | -13.2% | 0.00% | 0.0% |
| Q2 2019 | $44,000 | -89.5% | 1,064 | -88.2% | 0.00% | -88.9% |
| Q1 2019 | $419,000 | +6.3% | 8,988 | -0.6% | 0.01% | 0.0% |
| Q4 2018 | $394,000 | -56.3% | 9,044 | -42.5% | 0.01% | -50.0% |
| Q3 2018 | $901,000 | +15.7% | 15,736 | -1.9% | 0.02% | +12.5% |
| Q2 2018 | $779,000 | +39.6% | 16,044 | +12.4% | 0.02% | +166.7% |
| Q1 2018 | $558,000 | – | 14,280 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darwin Global Management, Ltd. | 938,490 | $120,070,000 | 33.50% |
| Foresite Capital Management III, LLC | 108,630 | $13,898,000 | 16.15% |
| Octagon Capital Advisors LP | 112,363 | $14,376,000 | 4.98% |
| Artal Group S.A. | 1,400,000 | $179,116,000 | 3.84% |
| Avoro Capital Advisors LLC | 1,550,000 | $198,307,000 | 3.42% |
| Affinity Asset Advisors, LLC | 45,000 | $5,757,000 | 3.05% |
| NWI MANAGEMENT LP | 200,000 | $25,588,000 | 2.54% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 71,000 | $9,063,000 | 2.48% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,600,000 | $332,644,000 | 2.00% |
| Parkman Healthcare Partners LLC | 52,458 | $6,711,000 | 1.72% |